News about Manufacturing

Upperton Pharma Solutions begins construction work at Nottingham facility

Work has now started in earnest to deliver the new, 50,000-square-foot facility, which is expected to be fully operational by the end of 2023

Manufacturing | 23/01/2023 | By Sudeep Soparkar |  403

Pfizer inks deal to acquire Abzena's manufacturing plant in North Carolina

Construction is ongoing at the location, which Abzena selected back in April 2021 for its access to a talented workforce and other resources

Manufacturing | 18/01/2023 | By Sudeep Soparkar |  1354

Lonza completes expansion at Oregon site

The project included the remodelling of laboratory space used to develop early-stage compounds

Manufacturing | 18/01/2023 | By Sudeep Soparkar |  688

Sai Life Sciences opens high-potency API manufacturing facility at Bidar Campus

The facility is spread across 16000 sq ft HPAPI block

Manufacturing | 17/01/2023 | By Sudeep Soparkar |  1575

Sterling Pharma Solutions acquires Novartis' API manufacturing facility in Ireland

The 111-acre site, located near Cork, includes multiple commercial-scale production buildings, with a total vessel capacity of 175 cubic meters across over 30 reactor trains

Manufacturing | 11/01/2023 | By Sudeep Soparkar |  1360

Agilent Technologies to spend $725 M to double production capacity of therapeutic nucleic acids

Two new manufacturing lines—called Trains C and D—will be added to the company’s Frederick, Colorado, facility

Manufacturing | 11/01/2023 | By Sudeep Soparkar |  997

Aurisco to build oligonucleotides manufacturing facility in China

The Oligo FlexFactory platform is the first of the three planned commercial manufacturing lines of Aurisco in Yangzhou of East China

Manufacturing | 06/01/2023 | By Sudeep Soparkar |  687

WuXi STA opens oral solids continuous manufacturing line

Operation has begun for CRDMO WuXi STA’s first continuous manufacturing line for oral solids, in Wuxi city, China
<br />

Manufacturing | 05/01/2023 | By Sudeep Soparkar |  733

Ablaze Pharmaceuticals, Yonghe Pharmaceutical in manufacturing agreement

Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze from pharmaceutical research and preclinical activities to clinical studies

Manufacturing | 29/12/2022 | By Sudeep Soparkar |  675

Shanghai-based Everest Medicines commences operations at its mRNA vaccine manufacturing facility

The first phase of the project, covering an area of 58,000 square meters and with an investment of more than RMB 900 million, has a set of advanced production facilities built to meet global and China GMP standards
<br />

Manufacturing | 28/12/2022 | By Sudeep Soparkar |  805